【摘要】：目的:觀察美羅培南聯(lián)合萬(wàn)古霉素鞘內(nèi)注射治療開(kāi)顱術(shù)后顱內(nèi)感染的臨床療效及安全性。方法:采用回顧性分析方法,選擇我院2014年5月-2016年6月開(kāi)顱術(shù)后顱內(nèi)感染患者46例,按照治療方法分為對(duì)照組(20例)和觀察組(26例)。對(duì)照組患者給予注射用鹽酸萬(wàn)古霉素1.0 g,ivgtt,bid+注射用美羅培南2.0 g,ivgtt,tid;觀察組患者行腰大池置管引流釋放腦脊液后,緩慢給予注射用鹽酸萬(wàn)古霉素20 mg,用0.9%氯化鈉注射液2 mL沖管后,緩慢給予注射用美羅培南20 mg,bid。兩組患者均治療2周。觀察兩組患者腦脊液細(xì)菌培養(yǎng)情況、臨床療效、治愈時(shí)間及其治療費(fèi)用,并記錄不良反應(yīng)和治療后6個(gè)月的后遺癥發(fā)生情況。結(jié)果:46例患者腦脊液細(xì)菌培養(yǎng)陽(yáng)性率為45.7%。觀察組患者痊愈率(92.3%)顯著高于對(duì)照組(65.0%),治愈時(shí)間及其治療費(fèi)用均顯著短/低于對(duì)照組;總不良反應(yīng)發(fā)生率(7.7%)顯著低于對(duì)照組(40.0%),后遺癥發(fā)生率(3.8%)顯著低于對(duì)照組(20.0%),差異均有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:美羅培南聯(lián)合萬(wàn)古霉素鞘內(nèi)注射治療開(kāi)顱術(shù)后顱內(nèi)感染的療效優(yōu)于靜脈給藥,可顯著縮短治療時(shí)間,降低治療費(fèi)用,且安全性較好。
[Abstract]:Objective: to observe the clinical efficacy and safety of meropenem combined with vancomycin intrathecal injection in the treatment of intracranial infection after craniotomy. Methods: 46 patients with intracranial infection after craniotomy in our hospital from May 2014 to June 2016 were selected and divided into control group (n = 20) and observation group (n = 26) according to the treatment method. The patients in the control group were given vancomycin hydrochloric acid 1.0 g, ivgtt, bid for meropenem 2.0 g, ivgtt, tid. after drainage and release of cerebrospinal fluid in the lumbar cistern, the patients in the observation group were slowly given vancomycin hydrochloric acid 20 mg, with 0.9% sodium chloride injection 2 mL, and meropenem 20 mg,bid. for injection Both groups were treated for 2 weeks. The bacterial culture, clinical curative effect, cure time and treatment cost of cerebrospinal fluid in the two groups were observed, and the adverse reactions and sequelae 6 months after treatment were recorded. Results: the positive rate of bacterial culture in cerebrospinal fluid of 46 patients was 45.7%. The cure rate (92.3%) in the observation group was significantly higher than that in the control group (65.0%), the cure time and treatment cost were significantly shorter / lower than those in the control group, the total incidence of adverse reactions (7.7%) was significantly lower than that in the control group (40.0%), and the incidence of sequelae (3.8%) was significantly lower than that in the control group (20.0%). Conclusion: the efficacy of meropenem combined with vancomycin intrathecal injection in the treatment of intracranial infection after craniotomy is better than that of intravenous administration, which can significantly shorten the treatment time, reduce the cost of treatment, and is safe.
【作者單位】： 民航總醫(yī)院重癥醫(yī)學(xué)科;
【分類號(hào)】：R651.1

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 劉玉霞;鞘內(nèi)注射治療橈骨莖突狹窄性腱鞘炎56例[J];中國(guó)民間療法;1999年12期

2 李巧玉,袁志誠(chéng),陸軍,湛利平,陸陪松;頭孢噻肟鞘內(nèi)注射治療開(kāi)顱術(shù)后顱內(nèi)感染31例[J];新醫(yī)學(xué);1999年07期

3 張文斗;張學(xué)創(chuàng);;鞘內(nèi)注射治療開(kāi)顱術(shù)后顱內(nèi)感染的臨床研究[J];中華醫(yī)院感染學(xué)雜志;2013年22期

4 楊鈞,董方箴,蔡琦,吳鋒,倪海濤,路偉,李錚,潘保根,野戰(zhàn)鷹;阿米卡星鞘內(nèi)注射治療顱內(nèi)術(shù)后感染32例臨床分析[J];武警醫(yī)學(xué);2004年10期

5 孫永安;馬正春;竇玉明;鄭廣文;張正文;;胞二磷膽堿鞘內(nèi)注射治療重度腦功能障礙11例[J];人民軍醫(yī);1993年05期

6 王麗娟,王國(guó)君;鞘內(nèi)注射治療手指縮窄性腱鞘炎260例臨床分析[J];吉林醫(yī)學(xué);1998年03期

7 劉興元;虞紅健;;鞘內(nèi)注射治療拇指屈肌腱鞘炎62例[J];中國(guó)社區(qū)醫(yī)師(醫(yī)學(xué)專業(yè)半月刊);2008年20期

8 朱剛勁;馬錦鵬;劉鐵生;韋云臻;周明擴(kuò);曾毅軍;;曲安奈德鞘內(nèi)注射治療指屈肌腱狹窄性腱鞘炎的臨床研究[J];中國(guó)現(xiàn)代藥物應(yīng)用;2014年04期

9 尤再春;周人杰;陳國(guó)柱;尹揚(yáng)光;李霞;李佳;;腦脊液置換術(shù)聯(lián)合鞘內(nèi)注射治療創(chuàng)傷性蛛網(wǎng)膜下腔出血臨床研究[J];重慶醫(yī)學(xué);2010年15期

10 武紀(jì)玲;;消定膏外敷聯(lián)合潑尼松龍鞘內(nèi)注射治療橈骨莖突狹窄性腱鞘炎30例[J];中醫(yī)研究;2013年03期

，

本文編號(hào)：2516307